EP Patent

EP3394044A1 — Tank-binding kinase inhibitor compounds

Assigned to Gilead Sciences Inc · Expires 2018-10-31 · 8y expired

What this patent protects

Compounds having the following formula (I) and methods of their use and preparation are disclosed.

USPTO Abstract

Compounds having the following formula (I) and methods of their use and preparation are disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP3394044A1
Jurisdiction
EP
Classification
—
Expires
2018-10-31
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.